Clinical trial · Observational
A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)
Clinical and Sociodemographic Characterization of Multiple Myeloma Patients With Symptomatic Relapse and/or Refractory Disease in Portugal: an Observational, Multicenter Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main aim of this study is to see how people with MM respond to previous or current treatment. Participants will be treated according to their clinic's standard practice. Each participant will fill out a study questionnaire during a routine doctor visit. Information collected from past medical records will also be used.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Relapse and/or Refractory Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Participants with MM
- description
- Participants diagnosed with MM from 8 investigative sites will be observed retrospectively for previous 5 years before enrollment until Day 1.
Primary outcomes (4)
- measure
- Number of MM Participants Categorized by Sociodemographic Variables
- timeFrame
- Day 1
- description
- The sociodemographic variables will include age (in years), sex (male or female), body mass index (BMI), area of residence (rural or urban), educational level (illiterate, no studies (can only read/write), primary studies, secondary studies, or university studies), cohabitation (lives alone, lives with the family, lives alone with help from a caregiver, daily, 2-3 times/week, permanent or night-time), degree of dependence (independent, dependent grade I- requires help to perform instrumental activities of daily living (IADL) at least once a day, dependent grade II- needs help to perform IADLs 2 or 3 times a day or dependent grade III- needs help to perform IADLs several times a day),working situation (unemployed, in active employment, temporarily/permanently disabled, retired, student, other, need for financial assistance (yes/no), physical activity (high, moderate/low, inactive), smoking habit (yes/no), alcohol use (yes/no).
- measure
- Number of MM Participants Categorized by Clinical Variables on Diagnosis and During Previous Relapses
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. At least one previous treatment line. 2. Symptomatic R/R disease in the previous 6 months to study enrolment. 3. Receiving treatment with an accurate and thorough data fulfilled in their participant's medical records available at the study site. 4. On regular follow-up for relapse and/or refractory disease during the recruitment period at the study site. 5. Capable of understanding and completing both QoL questionnaires (EORTC QLQ-C30 and EORTC QLQ-MY20). Exclusion Criteria: 1. Diagnosed with MM more than 5 years previous to inclusion in this study. 2. Diagnosed with any malignancy other than MM or its complications within the past 5 years. 3. Currently participating in a clinical trial for his MM or having participated in a clinical trial within 5 years before inclusion. 4. Diagnosed with any hematological disease other than MM or its complications.
References
Publications (0)
Data not yet available